In glioblastomas after bevacizumab therapy, hypoxia can persistently induce the expression of phosphorylated signal transducer and activator of transcription 3 (p-STAT3) in glioma cells, which preserves the mesenchymal transformation of normal neuroglial cells and the stemness of glioma cells [79]. Here, STAT3 is linked to central nervous system cancer.